题名

Effect of "Pleurotus tuber-regium" Polysaccharides Supplementation on the Progression of Diabetes Complications in Obese-Diabetic Rats

DOI

10.4077/CJP.2014.BAC245

作者

Hui-Yu Huang;Mallikarjuna Korivi;Hui-Ting Yang;Chi-Chang Huang;Ying-Ying Chaing;Ying-Chieh Tsai

关键词

dyslipidemia ; fatty acid composition ; hyperglycemia ; mushroom ; obesity

期刊名称

The Chinese Journal of Physiology

卷期/出版年月

57卷4期(2014 / 08 / 31)

页次

198 - 208

内容语文

英文

英文摘要

In this study, the effect of mushroom extracellular polysaccharides on fatty acid composition and liver peroxisome proliferator-activated receptor-alpha (PPAR-α) expression in obese-diabetic rats was investigated, and distinguished the association among anti-obesity, hypoglycemic and hypolipidemic properties. Extracellular polysaccharides from three different strains of Pleurotus tuber-regium were extracted and labeled as HP (high-percentage), MP (medium-percentage) and LP (low-percentage). Obesediabetes (OD) was induced by chronic high-fat diet plus streptozotocin (STZ) injections. Simultaneously to the diet, polysaccharides were orally administered to OD groups (20 mg/kg body weight/8-week), and categorized into OD+HP, OD+MP and OD+LP groups (n = 10/group), respectively. High-fat diet plus STZ-induced hyperglycemia was prominently attenuated by polysaccharides. Increased fatty acid component n-6/n-3 ratio in liver and plasma of obese-diabetic rats was attenuated, while, reduced MUFA/PUFA and MUFA/SFA ratios were restored (P < 0.01) with polysaccharides treatment. Furthermore, elevated serum total cholesterol, triglycerides and low-density lipoprotein (LDL) concentrations were controlled, and parallel restoration of decreased high-density lipoprotein (HDL) levels were found with polysaccharides supplementation. This hypolipidemic property might be associated with up-regulated liver PPAR-α mRNA expression and protein levels (P < 0.01). These findings concluded that stable fatty acid components and activated PPAR-α by polysaccharides may contribute to its hypoglycemic and hypolipidemic properties. Therefore, P. tuber-regium could be considered as nutritional supplement to treat diabetic complications.

主题分类 醫藥衛生 > 基礎醫學
参考文献
  1. Chen, S.C.,Liao, C.A.,Lee, S.D.,Chen, Y.L.,Lin, C.T.,Kao, C.L.,Kuo, C.H.(2012).Cross-generation link between inactive behavior of schoolchildren and metabolic disease category of parents.Chinese J. Physiol.,55,108-113.
    連結:
  2. Athyros, V.G.,Tziomalos, K.,Karagiannis, A.,Anagnostis, P.,Mikhailidis, D.P.(2010).Should adipokines be considered in the choice of the treatment of obesity-related health problems?.Curr. Drug Targets,11,122-135.
  3. Berger, J.P.,Akiyama, T.E.,Meinke, P.T.(2005).PPARs: therapeutic targets for metabolic disease.Trends Pharmacol. Sci.,26,244-251.
  4. Brooks, N.L.,Moore, K.S.,Clark, R.D.,Perfetti, M.T.,Trent, C.M.,Combs, T.P.(2007).Do low levels of circulating adiponectin represent a biomarker or just another risk factor for the metabolic syndrome?.Diabetes Obes. Metab.,9,246-257.
  5. Chang, R.(1996).Functional properties of edible mushrooms.Nutr. Rev.,54,S91-S93.
  6. Cheung, P.C.(1996).The hypocholesterolemic effect of two edible mushrooms Auricularia auricula tree-ear and Tremella fuciformis white jelly-leaf in hypercholesterolemic rats.Nutr. Res.,16,1721-1725.
  7. Cheung, P.C.,Lee, M.Y.(2000).Fractionation and characterization of mushroom dietary fiber (nonstarch polysaccharides) as potential nutraceuticals from sclerotia of Pleurotus tuber-regium (Fries) singer.J. Agric. Food Chem.,48,3148-3151.
  8. Cho, E.J.,Hwang, H.J.,Kim, S.W.,Oh, J.,Baek, Y.M.,Choi, J.W.,Bae, S.H.,Yun, J.W.(2007).Hypoglycemic effects of exopolysaccharides produced by mycelial cultures of two different mushrooms Tremella fuciformis and Phellinus baumii in ob/ob mice.Appl. Microbiol. Biotechnol.,75,1257-1265.
  9. Dahech, I.,Belghith, K.S.,Hamden, K.,Feki, A.,Belghith, H.,Mejdoub, H.(2011).Oral administration of levan polysaccharide reduces the alloxan-induced oxidative stress in rats.Int. J. Biol. Macromol.,49,942-947.
  10. Dong, Q.,Yao, J.,Yang, X.T.,Fang, J.N.(2002).Structural characterization of a water-soluble beta-D-glucan from fruiting bodies of Agaricus blazei Murr.Carbohydr. Res.,337,1417-1421.
  11. Ellis, P.R.,Rayment, P.,Wang, Q.(1996).A physico-chemical perspective of plant polysaccharides in relation to glucose absorption, insulin secretion and the entero-insular axis.Proc. Nutr. Soc.,55,881-898.
  12. Erkkilä, A.T.,Lehto, S.,Pyörälä, K.,Uusitupa, M.I.(2003).n-3 Fatty acids and 5-y risks of death and cardiovascular disease events in patients with coronary artery disease.Am. J. Clin. Nutr.,78,65-71.
  13. Feskens, E.J.,Bowles, C.H.,Kromhout, D.(1991).Inverse association between fish intake and risk of glucose intolerance in normoglycemic elderly men and women.Diabetes Care,14,935-941.
  14. Fujioka, S.,Matsuzawa, Y.,Tokunaga, K.,Kawamoto, T.,Kobatake, T.,Keno, Y.,Kotani, K.,Yoshida, S.,Tarui, S.(1991).Improvement of glucose and lipid metabolism associated with selective reduction of intra-abdominal visceral fat in premenopausal women with visceral fat obesity.Int. J. Obes.,15,853-859.
  15. Fukuchi, S.,Hamaguchi, K.,Seike, M.,Himeno, K.,Sakata, T.,Yoshimatsu, H.(2004).Role of fatty acid composition in the development of metabolic disorders in sucrose-induced obese rats.Exp. Biol. Med. (Maywood),229,486-493.
  16. Garber, A.J.,Karlsson, F.O.(2001).Treatment of dyslipidemia in diabetes.Endocrinol. Metab. Clin. North Am.,30,999-1010.
  17. Han, S.B.,Yoon, Y.D.,Ahn, H.J.,Lee, H.S.,Lee, C.W.,Yoon, W.K.,Park, S.K.,Kim, H.M.(2003).Toll-like receptor-mediated activation of B cells and macrophages by polysaccharide isolated from cell culture of Acanthopanax senticosus.Int. Immunopharmacol.,3,1301-1312.
  18. Hiwatashi, K.,Kosaka, Y.,Suzuki, N.,Hata, K.,Mukaiyama, T.,Sakamoto, K.,Shirakawa, H.,Komai, M.(2010).Yamabushitake mushroom (Hericium erinaceus) improved lipid metabolism in mice fed a high-fat diet.Biosci. Biotechnol. Biochem.,74,1447-1451.
  19. Hofer, M.,Pospíšil, M.(2011).Modulation of animal and human hematopoiesis by β-glucans: a review.Molecules,16,7969-7979.
  20. Hu, S.H.,Wang, J.C.,Lien, J.L.,Liaw, E.T.,Lee, M.Y.(2006).Antihyperglycemic effect of polysaccharide from fermented broth of Pleurotus citrinopileatus.Appl. Microbiol. Biotechnol.,70,107-113.
  21. Huang, H.Y.,Korivi, M.,Chaing, Y.Y.,Chien, T.Y.,Tsai, Y.C.(2012).Pleurotus tuber-regium polysaccharides attenuate hyperglycemia and oxidative stress in experimental diabetic rats.Evid. Based Complement. Alternat. Med.,2012,856381.
  22. Inafuku, M.,Nagao, K.,Nomura, S.,Shirouchi, B.,Inoue, N.,Nagamori, N.,Nakayama, H.,Toda, T.,Yanagita, T.(2012).Protective effects of fractional extracts from Panellus serotinus on nonalcoholic fatty liver disease in obese, diabetic db/db mice.Brit. J. Nutr.,107,639-646.
  23. Jay, M.A.,Ren, J.(2007).Peroxisome proliferator-activated receptor (PPAR) in metabolic syndrome and type 2 diabetes mellitus.Curr. Diabetes Rev.,3,33-39.
  24. Jeong, S.C.,Jeong, Y.T.,Yang, B.K.,Islam, R.,Koyyalamudi, S.R.,Pang, G.,Cho, K.Y.,Song, C.H.(2010).White button mushroom (Agaricus bisporus) lowers blood glucose and cholesterol levels in diabetic and hypercholesterolemic rats.Nutr. Res.,30,49-56.
  25. Kadiri, M.,Fasidi, I.O.(1990).Studies on enzyme activities of Pleurotus tuber-regium (Fries) Singer and Tricholoma lobayensis Heim at various fruitbody stages.Food / Nahrung,34,695-699.
  26. Khondkar, P.,Aidoo, K.E.,Tester, R.F.(2002).Sugar profile of extracellular polysaccharides from different Tremella species.Int. J. Food Microbiol.,79,121-129.
  27. Kiho, T.,Morimoto, H.,Kobayashi, T.,Usui, S.,Ukai, S.,Aizawa, K.,Inakuma, T.(2000).Effect of a polysaccharide (TAP) from the fruiting bodies of Tremella aurantia on glucose metabolism in mouse liver.Biosci. Biotechnol. Biochem.,64,417-419.
  28. Kopelman, P.G.(2000).Obesity as a medical problem.Nature,404,635-643.
  29. Krachler, B.,Norberg, M.,Eriksson, J.W.,Hallmans, G.,Johansson, I.,Vessby, B.,Weinehall, L.,Lindahl, B.(2008).Fatty acid profile of the erythrocyte membrane preceding development of Type 2 diabetes mellitus.Nutr. Metab. Cardiovasc. Dis.,18,503-510.
  30. la Fleur, S.E.,Luijendijk, M.C.,van Rozen, A.J.,Kalsbeek, A.,Adan, R.A.(2011).A free-choice high-fat high-sugar diet induces glucose intolerance and insulin unresponsiveness to a glucose load not explained by obesity.Int. J. Obes. (Lond),35,595-604.
  31. Lo, H.C.,Tsai, F.A.,Wasser, S.P.,Yang, J.G.,Huang, B.M.(2006).Effects of ingested fruiting bodies, submerged culture biomass, and acidic polysaccharide glucuronoxylomannan of Tremella mesenterica Retz.:Fr. on glycemic responses in normal and diabetic rats.Life Sci.,78,1957-1966.
  32. Lo, H.C.,Tu, S.T.,Lin, K.C.,Lin, S.C.(2004).The anti-hyperglycemic activity of the fruiting body of Cordyceps in diabetic rats induced by nicotinamide and streptozotocin.Life Sci.,74,2897-2908.
  33. Marchetti, E.,Monaco, A.,Procaccini, L.,Mummolo, S.,Gatto, R.,Tetè, S.,Baldini, A.,Tecco, S.,Marzo, G.(2012).Periodontal disease: the influence of metabolic syndrome.Nutr. Metab. (Lond),9,88.
  34. Masiello, P.,Broca, C.,Gross, R.,Roye, M.,Manteghetti, M.,Hillaire-Buys, D.,Novelli, M.,Ribes, G.(1998).Experimental NIDDM: development of a new model in adult rats administered streptozotocin and nicotinamide.Diabetes,47,224-229.
  35. Pan, D.A.,Hulbert, A.J.,Storlien, L.H.(1994).Dietary fats, membrane phospholipids and obesity.J. Nutr.,124,1555-1565.
  36. Raza, H.,Prabu, S.K.,Robin, M.A.,Avadhani, N.G.(2004).Elevated mitochondrial cytochrome P450 2E1 and glutathione S-transferase A4-4 in streptozotocin-induced diabetic rats: tissue-specific variations and roles in oxidative stress.Diabetes,53,185-194.
  37. Ruggiero, C.,Ehrenshaft, M.,Cleland, E.,Stadler, K.(2011).High-fat diet induces an initial adaptation of mitochondrial bioenergetics in the kidney despite evident oxidative stress and mitochondrial ROS production.Am. J. Physiol. Endocrinol. Metab.,300,E1047-E1058.
  38. Schulze, M.B.,Rimm, E.B.,Shai, I.,Rifai, N.,Hu, F.B.(2004).Relationship between adiponectin and glycemic control, blood lipids, and inflammatory markers in men with type 2 diabetes.Diabetes Care,27,1680-1687.
  39. Shaw, J.E.,Sicree, R.A.,Zimmet, P.Z.(2010).Global estimates of the prevalence of diabetes for 2010 and 2030.Diabetes Res. Clin. Pract.,87,4-14.
  40. Srinivasan, K.,Viswanad, B.,Asrat, L.,Kaul, C.L.,Ramarao, P.(2005).Combination of high-fat diet-fed and low-dose streptozotocintreated rat: a model for type 2 diabetes and pharmacological screening.Pharmacol. Res.,52,313-320.
  41. Sun, J.E.,Ao, Z.H.,Lu, Z.M.,Xu, H.Y.,Zhang, X.M.,Dou, W.F.,Xu, Z.H.(2008).Antihyperglycemic and antilipidperoxidative effects of dry matter of culture broth of Inonotus obliquus in submerged culture on normal and alloxan-diabetes mice.J. Ethnopharmacol.,118,7-13.
  42. Webb, D.R.,Khunti, K.,Chatterjee, S.,Jarvis, J.,Davies, M.J.(2013).Adipocytokine associations with insulin resistance in british South Asians.J. Diabetes Res.,2013,561016.
  43. Yoshioka, Y.,Tabeta, R.,Saitô, H.,Uehara, N.,Fukuoka, F.(1985).Antitumor polysaccharides from P. ostreatus (Fr.) Quél.: isolation and structure of a beta-glucan.Carbohydr. Res.,140,93-100.